BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

SARS-CoV-2 infects brain choroid plexusA team from Medical Research Council Laboratory of Molecular Biology (MRC LMB) have found that SARS-CoV-2 infects the CSF-producing brain choroid plexus — but not...
BioCentury | Feb 20, 2020
Emerging Company Profile

C. Light opens retinal window to neurological disease

...Sheehy and Zachary Helft University collaborators: University of California Berkeley, University of California San Francisco, University of Pennsylvania Medical Center...
BioCentury | Mar 20, 2019
Politics & Policy

National Academies: Equitable access to medicines key to curbing opioid abuse disorder

...provide medication-based treatment as a condition of participation. Alkermes has a performance-based arrangement with the University of Pennsylvania Medical Center...
BioCentury | Mar 24, 2017
Clinical News

Donor exosomes could provide an early warning of transplant failure

...the technology are available for licensing and the university is seeking commercial partners. Michael Leviten Exosome Diagnostics Inc. University of Pennsylvania Medical Center Transplant...
BioCentury | May 11, 2015
Clinical News

rAAV2-CBSB-hRPE65: Phase I data

...visual sensitivity in all patients. Data were published in The New England Journal of Medicine. University of Pennsylvania Medical Center...
BioCentury | Sep 17, 2012
Company News

CRI Lifetree, University of Pennsylvania, University of Washington neurology news

...and complete enrollment by the end of next year. CRI Lifetree , Mount Laurel, N.J. University of Pennsylvania Medical Center...
BioCentury | Aug 7, 2012
Clinical News

NIH awards $18.5 million for NSAID consortium

...The consortium will be led by the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania medical...
BioCentury | Feb 27, 2012
Clinical News

AAV2-hRPE65v2: Additional Phase I data

...vision, including dark adaptometry, pupillometry, electroretinography, nystagmus and ambulatory behavior (see BioCentury, Nov. 2, 2009). University of Pennsylvania Medical Center...
BioCentury | Mar 15, 2010
Clinical News

University of Pennsylvania Medical Center preclinical data

...Researchers at the University of Pennsylvania Medical Center and colleagues reported data from a study in 6 dogs with congenital...
...vision, including dark adaptometry, pupillometry, electroretinography, nystagmus and ambulatory behavior (see BioCentury, Nov. 2, 2009). University of Pennsylvania Medical Center...
BioCentury | Nov 2, 2009
Clinical News

AAV2-hRPE65v2: Phase I data

...Researchers at the University of Pennsylvania Medical Center and colleagues reported data from an open-label Phase I trial in 12...
...of light sensitivity as that of age-matched normal-sighted individuals. Data were published in The Lancet. University of Pennsylvania Medical Center...
Items per page:
1 - 10 of 14
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

SARS-CoV-2 infects brain choroid plexusA team from Medical Research Council Laboratory of Molecular Biology (MRC LMB) have found that SARS-CoV-2 infects the CSF-producing brain choroid plexus — but not...
BioCentury | Feb 20, 2020
Emerging Company Profile

C. Light opens retinal window to neurological disease

...Sheehy and Zachary Helft University collaborators: University of California Berkeley, University of California San Francisco, University of Pennsylvania Medical Center...
BioCentury | Mar 20, 2019
Politics & Policy

National Academies: Equitable access to medicines key to curbing opioid abuse disorder

...provide medication-based treatment as a condition of participation. Alkermes has a performance-based arrangement with the University of Pennsylvania Medical Center...
BioCentury | Mar 24, 2017
Clinical News

Donor exosomes could provide an early warning of transplant failure

...the technology are available for licensing and the university is seeking commercial partners. Michael Leviten Exosome Diagnostics Inc. University of Pennsylvania Medical Center Transplant...
BioCentury | May 11, 2015
Clinical News

rAAV2-CBSB-hRPE65: Phase I data

...visual sensitivity in all patients. Data were published in The New England Journal of Medicine. University of Pennsylvania Medical Center...
BioCentury | Sep 17, 2012
Company News

CRI Lifetree, University of Pennsylvania, University of Washington neurology news

...and complete enrollment by the end of next year. CRI Lifetree , Mount Laurel, N.J. University of Pennsylvania Medical Center...
BioCentury | Aug 7, 2012
Clinical News

NIH awards $18.5 million for NSAID consortium

...The consortium will be led by the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania medical...
BioCentury | Feb 27, 2012
Clinical News

AAV2-hRPE65v2: Additional Phase I data

...vision, including dark adaptometry, pupillometry, electroretinography, nystagmus and ambulatory behavior (see BioCentury, Nov. 2, 2009). University of Pennsylvania Medical Center...
BioCentury | Mar 15, 2010
Clinical News

University of Pennsylvania Medical Center preclinical data

...Researchers at the University of Pennsylvania Medical Center and colleagues reported data from a study in 6 dogs with congenital...
...vision, including dark adaptometry, pupillometry, electroretinography, nystagmus and ambulatory behavior (see BioCentury, Nov. 2, 2009). University of Pennsylvania Medical Center...
BioCentury | Nov 2, 2009
Clinical News

AAV2-hRPE65v2: Phase I data

...Researchers at the University of Pennsylvania Medical Center and colleagues reported data from an open-label Phase I trial in 12...
...of light sensitivity as that of age-matched normal-sighted individuals. Data were published in The Lancet. University of Pennsylvania Medical Center...
Items per page:
1 - 10 of 14